46.92
Precedente Chiudi:
$47.90
Aprire:
$47.9
Volume 24 ore:
419.84K
Relative Volume:
1.05
Capitalizzazione di mercato:
$987.47M
Reddito:
$1.77M
Utile/perdita netta:
$-123.74M
Rapporto P/E:
-5.1167
EPS:
-9.17
Flusso di cassa netto:
$-95.21M
1 W Prestazione:
+3.69%
1M Prestazione:
-20.77%
6M Prestazione:
-27.85%
1 anno Prestazione:
-12.33%
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Nome
Praxis Precision Medicines Inc
Settore
Industria
Telefono
617-300-8460
Indirizzo
99 HIGH STREET, 30TH FLOOR, BOSTON
Confronta PRAX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PRAX
Praxis Precision Medicines Inc
|
46.92 | 1.01B | 1.77M | -123.74M | -95.21M | -9.17 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-02 | Ripresa | Oppenheimer | Outperform |
2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
2025-03-03 | Reiterato | H.C. Wainwright | Buy |
2025-02-11 | Iniziato | Deutsche Bank | Buy |
2024-08-05 | Iniziato | Oppenheimer | Outperform |
2024-06-24 | Iniziato | Needham | Buy |
2024-06-18 | Iniziato | Guggenheim | Buy |
2024-05-01 | Iniziato | Robert W. Baird | Outperform |
2023-09-19 | Iniziato | Truist | Buy |
2022-06-06 | Downgrade | Wedbush | Outperform → Neutral |
2021-12-16 | Iniziato | H.C. Wainwright | Buy |
2021-08-26 | Iniziato | BofA Securities | Buy |
2021-04-26 | Iniziato | William Blair | Outperform |
2020-11-11 | Iniziato | Wedbush | Outperform |
2020-11-10 | Iniziato | Cowen | Outperform |
2020-11-10 | Iniziato | Evercore ISI | Outperform |
2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie
How to read the order book for Praxis Precision Medicines Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser
Published on: 2025-08-27 11:04:13 - Newser
Published on: 2025-08-27 10:56:50 - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc.PRAX - PR Newswire
Using AI based signals to follow Praxis Precision Medicines Inc.Quarterly Market Review & Accurate Buy Signal Notifications - Newser
How sentiment analysis helps forecast Praxis Precision Medicines Inc.Market Trend Report & Fast Entry Momentum Alerts - Newser
Deutsche Bank AG Decreases Position in Praxis Precision Medicines, Inc. $PRAX - Defense World
Comparing Praxis Precision Medicines Inc. in custom built stock radarsEarnings Trend Report & Trade Opportunity Analysis Reports - Newser
How to build a dashboard for Praxis Precision Medicines Inc. stockEarnings Beat & Safe Swing Trade Setups - Newser
Reversal indicators forming on Praxis Precision Medicines Inc. stockPrice Action & Stepwise Entry and Exit Trade Signals - Newser
Published on: 2025-08-26 18:53:26 - Newser
News impact scoring models applied to Praxis Precision Medicines Inc.Market Risk Summary & Long-Term Capital Growth Ideas - Newser
Top chart patterns to watch in Praxis Precision Medicines Inc.2025 Earnings Surprises & Verified High Yield Trade Plans - Newser
Analyzing Praxis Precision Medicines Inc. with risk reward ratio charts - Newser
Swiss National Bank Has $1.03 Million Stock Position in Praxis Precision Medicines, Inc. $PRAX - Defense World
Measuring Praxis Precision Medicines Inc.’s beta against major indicesWeekly Investment Recap & Weekly Top Stock Performers List - Newser
Praxis Precision Medicines to Present Recent Epilepsy Study Results at International Epilepsy Congress 2025 - Quiver Quantitative
Praxis Medicines to Present at 36th International Epilepsy - GlobeNewswire
12 Breakthrough Epilepsy Treatment Studies: Praxis Medicines to Reveal Latest RADIANT Data at Global Congress - Stock Titan
Evaluating Praxis Precision Medicines Inc. with trendline analysisQuarterly Trade Review & Consistent Income Trade Ideas - Newser
Is Praxis Precision Medicines Inc. reversing from oversold territoryMarket Growth Review & High Conviction Investment Ideas - Newser
Tools to monitor Praxis Precision Medicines Inc. recovery probabilityJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Can machine learning forecast Praxis Precision Medicines Inc. recoveryQuarterly Investment Review & AI Forecasted Stock Moves - Newser
Top chart patterns to watch in Praxis Precision Medicines IncJuly 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Market Review: Can Praxis Precision Medicines Inc. be recession proofJuly 2025 EndofMonth & Safe Entry Zone Tips - sundaytimes.kr
Can Praxis Precision Medicines Inc. rally from current levelsMarket Volume Summary & Fast Exit and Entry Strategy Plans - Newser
What Technical Tools Say About Praxis Precision Medicines Inc. RecoveryJuly 2025 Price Swings & Entry and Exit Point Strategies - beatles.ru
Praxis Precision Medicines Under Investigation for Securities Law Violations - AInvest
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Praxis Precision Medicines, Inc. (PRAX) And Encourages Investors to Connect - ACCESS Newswire
Intraday Charts Show Spike in Praxis Precision Medicines Inc. ActivityStop Loss & Free Real-Time Market Sentiment Alerts - 더경남뉴스
Praxis Precision Medicines Inc. stock momentum explainedQuarterly Investment Review & Safe Entry Trade Reports - Newser
Advanced analytics toolkit walkthrough for Praxis Precision Medicines Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Praxis Precision Medicines Inc. stock retracement – recovery analysisJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
Momentum Screeners Rank Praxis Precision Medicines Inc. in Top 5 TodayJuly 2025 News Drivers & Detailed Earnings Play Alerts - beatles.ru
Praxis Precision Medicines Inc Azioni (PRAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Praxis Precision Medicines Inc Azioni (PRAX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Sale |
80.20 |
8,239 |
660,827 |
10,301 |
Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Option Exercise |
56.94 |
4,374 |
249,056 |
10,801 |
Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Sale |
81.78 |
5,188 |
424,318 |
5,613 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):